author-photo

Michèle Beau-Faller

University of Strasbourg

108

Papers

2677

Citations

Citation Trend

Filter By

Papers (108) Sort By

Journal Conference Others

Molecular Mechanism of EGFR-TKI Resistance in EGFR-Mutated Non-Small Cell Lung Cancer: Application to Biological Diagnostic and Monitoring

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (1)
Cancer du poumon : quel bilan de biologie moléculaire ?: Lung cancer: what is the molecular biology assessment?

2021 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Comparisons of outcomes between first and second generations EGFR-TKIs in stage IV non-small cell lung cancer harboring EGFR mutations

2020 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
PTEN, ATM, IDH1 mutations and MAPK pathway activation as modulators of PFS and OS in patients treated by first line EGFR TKI, an ancillary study of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Inequity in access to personalized medicine in France: Evidences from analysis of geo variations in the access to molecular profiling among advanced non-small-cell lung cancer patients: Results from the IFCT Biomarkers France Study.

2020 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (1)
Valeur pronostique des substitutions d’acide aminé de KRAS dans les adénocarcinomes pulmonaires en récidive traités par immunothérapie dans une cohorte française rétrospective

2020 Revue des Maladies Respiratoires Actualités
Show All
- Source
- Cite
- Save
Citations (0)
Outcomes of advanced Non-Small Cell Lung Cancer patients From the IFCT Biomarkers France study by KRAS Mutation Subtypes

2020
Show All
- Source
- Cite
- Save
Citations (1)
Brief report : High MET overexpression does not predict the presence of MET exon 14 splice mutations in NSCLC : results from the IFCT Predict.amm study

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (13)
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790 M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): results of the French Cooperative Thoracic Intergroup (IFCT) Biomarkers France project

2019 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Activity of epidermal growth factor tyrosine kinase inhibitors in non-small cell lung carcinoma with refractory leptomeningeal metastases.

2019 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (12)